HUP0401125A2 - Eljárás fexofenadine, egy piperidinszármazék és új közbenső termékei előállítására - Google Patents
Eljárás fexofenadine, egy piperidinszármazék és új közbenső termékei előállításáraInfo
- Publication number
- HUP0401125A2 HUP0401125A2 HU0401125A HUP0401125A HUP0401125A2 HU P0401125 A2 HUP0401125 A2 HU P0401125A2 HU 0401125 A HU0401125 A HU 0401125A HU P0401125 A HUP0401125 A HU P0401125A HU P0401125 A2 HUP0401125 A2 HU P0401125A2
- Authority
- HU
- Hungary
- Prior art keywords
- production
- fexofenadine
- new intermediates
- hydroxyl
- group
- Prior art date
Links
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003592 fexofenadine Drugs 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title abstract 2
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229940008201 allegra Drugs 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29839701P | 2001-06-15 | 2001-06-15 | |
| PCT/EP2002/006424 WO2002102776A1 (en) | 2001-06-15 | 2002-06-12 | Process for the production of the piperidine derivative fexofenadine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0401125A2 true HUP0401125A2 (hu) | 2004-09-28 |
Family
ID=23150325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401125A HUP0401125A2 (hu) | 2001-06-15 | 2002-06-12 | Eljárás fexofenadine, egy piperidinszármazék és új közbenső termékei előállítására |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6743941B2 (enExample) |
| EP (1) | EP1401816B1 (enExample) |
| JP (1) | JP4344230B2 (enExample) |
| KR (1) | KR100903285B1 (enExample) |
| CN (1) | CN1229347C (enExample) |
| AR (1) | AR037005A1 (enExample) |
| AT (1) | ATE386021T1 (enExample) |
| AU (1) | AU2002320847B2 (enExample) |
| BR (1) | BR0210410A (enExample) |
| CA (1) | CA2450313C (enExample) |
| DE (1) | DE60225008T2 (enExample) |
| DK (1) | DK1401816T3 (enExample) |
| ES (1) | ES2298384T3 (enExample) |
| HU (1) | HUP0401125A2 (enExample) |
| IL (2) | IL159304A0 (enExample) |
| MX (1) | MXPA03010960A (enExample) |
| NO (1) | NO20035572L (enExample) |
| NZ (1) | NZ530153A (enExample) |
| PL (1) | PL364369A1 (enExample) |
| PT (1) | PT1401816E (enExample) |
| WO (1) | WO2002102776A1 (enExample) |
| ZA (1) | ZA200308697B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7498345B2 (en) * | 2004-09-17 | 2009-03-03 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| US7498443B2 (en) * | 2004-09-17 | 2009-03-03 | Albany Molecular Research, Inc. | Process for production of carebastine |
| CN100453522C (zh) * | 2005-01-26 | 2009-01-21 | 中国科学技术大学 | 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法 |
| WO2007135693A2 (en) * | 2006-05-18 | 2007-11-29 | Ind-Swift Laboratories Limited | Intermediates useful for the preparation of antihistaminic piperidine derivative |
| ITMI20061491A1 (it) * | 2006-07-27 | 2008-01-28 | Archimica Srl | Processo per la preparazione di fexofenadina. |
| ITMI20061492A1 (it) * | 2006-07-27 | 2008-01-28 | Archimica Srl | Processo per la preparazione di fexofenadina. |
| CN102070570A (zh) * | 2009-11-21 | 2011-05-25 | 浙江华海药业股份有限公司 | 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法 |
| CN102070490B (zh) * | 2009-11-21 | 2014-07-30 | 浙江华海药业股份有限公司 | 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法 |
| US9896445B2 (en) | 2015-06-15 | 2018-02-20 | Ansana BioSciences, LLC | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer |
| CN104876853B (zh) * | 2015-06-17 | 2017-06-16 | 苏州卫生职业技术学院 | 盐酸非索非那定的合成方法 |
| PL3365327T3 (pl) | 2015-10-22 | 2020-05-18 | Sanofi-Aventis Deutschland Gmbh | Sposób wytwarzania feksofenadyny i związki pośrednie stosowane w tym sposobie |
| WO2018183762A1 (en) | 2017-03-29 | 2018-10-04 | United States Government As Represented By The Department Of Veterans Affairs | Methods and compositions for treating cancer |
| TW202128665A (zh) | 2019-10-28 | 2021-08-01 | 美商阿沙納生物科學公司 | 使用ｅｒｋ１與ｅｒｋ２之雜環抑制劑之改良之方法、套組、組成物及給藥攝生法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2946809A1 (de) * | 1979-11-20 | 1981-06-11 | A. Nattermann & Cie GmbH, 5000 Köln | 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel |
| IT1200123B (it) | 1985-09-27 | 1989-01-05 | Ind Chimica Srl | Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo |
| EP0347123A3 (en) | 1988-06-17 | 1991-07-03 | Fisons Corporation | Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties |
| IT1249684B (it) | 1991-07-19 | 1995-03-09 | Sorin Biomedica Spa | Epitopi della proteina env del virus dell'epatite c. |
| ATE220666T1 (de) * | 1992-04-10 | 2002-08-15 | Merrell Pharma Inc | 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung |
| KR100387347B1 (ko) | 1993-06-24 | 2003-11-28 | 알바니 몰레큘라 리써치, 인크. | 피페리딘 유도체 및 그의 제조 방법 |
-
2002
- 2002-06-11 US US10/166,893 patent/US6743941B2/en not_active Expired - Lifetime
- 2002-06-12 MX MXPA03010960A patent/MXPA03010960A/es active IP Right Grant
- 2002-06-12 AU AU2002320847A patent/AU2002320847B2/en not_active Ceased
- 2002-06-12 DE DE60225008T patent/DE60225008T2/de not_active Expired - Lifetime
- 2002-06-12 NZ NZ530153A patent/NZ530153A/en not_active IP Right Cessation
- 2002-06-12 BR BR0210410-5A patent/BR0210410A/pt not_active IP Right Cessation
- 2002-06-12 PL PL02364369A patent/PL364369A1/xx not_active Application Discontinuation
- 2002-06-12 JP JP2003505319A patent/JP4344230B2/ja not_active Expired - Fee Related
- 2002-06-12 CA CA2450313A patent/CA2450313C/en not_active Expired - Fee Related
- 2002-06-12 CN CNB028119312A patent/CN1229347C/zh not_active Expired - Fee Related
- 2002-06-12 HU HU0401125A patent/HUP0401125A2/hu unknown
- 2002-06-12 AT AT02754657T patent/ATE386021T1/de active
- 2002-06-12 KR KR1020037016429A patent/KR100903285B1/ko not_active Expired - Fee Related
- 2002-06-12 ES ES02754657T patent/ES2298384T3/es not_active Expired - Lifetime
- 2002-06-12 WO PCT/EP2002/006424 patent/WO2002102776A1/en not_active Ceased
- 2002-06-12 PT PT02754657T patent/PT1401816E/pt unknown
- 2002-06-12 EP EP02754657A patent/EP1401816B1/en not_active Expired - Lifetime
- 2002-06-12 IL IL15930402A patent/IL159304A0/xx unknown
- 2002-06-12 DK DK02754657T patent/DK1401816T3/da active
- 2002-06-14 AR ARP020102261A patent/AR037005A1/es unknown
-
2003
- 2003-11-07 ZA ZA200308697A patent/ZA200308697B/en unknown
- 2003-12-10 IL IL159304A patent/IL159304A/en not_active IP Right Cessation
- 2003-12-12 NO NO20035572A patent/NO20035572L/no unknown
-
2004
- 2004-04-22 US US10/829,803 patent/US7235665B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO20035572L (no) | 2004-02-16 |
| ES2298384T3 (es) | 2008-05-16 |
| DE60225008D1 (de) | 2008-03-27 |
| ATE386021T1 (de) | 2008-03-15 |
| ZA200308697B (en) | 2004-09-03 |
| EP1401816A1 (en) | 2004-03-31 |
| MXPA03010960A (es) | 2004-02-27 |
| DK1401816T3 (da) | 2008-06-09 |
| US20030105329A1 (en) | 2003-06-05 |
| CN1229347C (zh) | 2005-11-30 |
| US7235665B2 (en) | 2007-06-26 |
| DE60225008T2 (de) | 2009-01-29 |
| AU2002320847B2 (en) | 2007-09-20 |
| PT1401816E (pt) | 2008-04-08 |
| CA2450313C (en) | 2010-08-10 |
| WO2002102776A1 (en) | 2002-12-27 |
| KR100903285B1 (ko) | 2009-06-17 |
| BR0210410A (pt) | 2004-08-17 |
| NZ530153A (en) | 2005-07-29 |
| AR037005A1 (es) | 2004-10-20 |
| CA2450313A1 (en) | 2002-12-27 |
| EP1401816B1 (en) | 2008-02-13 |
| HK1063795A1 (en) | 2005-01-14 |
| JP4344230B2 (ja) | 2009-10-14 |
| CN1516689A (zh) | 2004-07-28 |
| IL159304A (en) | 2010-02-17 |
| US6743941B2 (en) | 2004-06-01 |
| JP2005502603A (ja) | 2005-01-27 |
| NO20035572D0 (no) | 2003-12-12 |
| US20040198983A1 (en) | 2004-10-07 |
| IL159304A0 (en) | 2004-06-01 |
| PL364369A1 (en) | 2004-12-13 |
| KR20040010720A (ko) | 2004-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401125A2 (hu) | Eljárás fexofenadine, egy piperidinszármazék és új közbenső termékei előállítására | |
| HUP0003309A2 (hu) | Imidazolilcsoportot tartalmazó gyűrűs acetálok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| DE69904302D1 (de) | Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| CY1110831T1 (el) | Αντι-ιικα μεσα τυπου διαζαινδολο-δικαρβονυλο-πιπεραζινυλιου | |
| DK0871606T3 (da) | Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| HUP9700997A1 (hu) | Benzimidazolszármazékok és e vegyületeket tartalmazó, antihisztamin hatású gyógyászati készítmények | |
| HUP0001115A2 (en) | Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same | |
| HUP0004592A2 (hu) | VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások | |
| HUP0400365A2 (hu) | 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0302792A2 (hu) | Dipeptidil peptidáz ciklopropil-kondenzált pirrolidin-bázisú inhibitorai és eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0102102A2 (hu) | Pirazolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0302157A2 (hu) | 4-(2-Fenil-tiazol-5-il)-1,4-diazabiciklo[3.2.2]nonán-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0401886A2 (hu) | Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| DE69308029D1 (de) | 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOCHINOLINAMINE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS THERAPEUTIKA | |
| ATE148108T1 (de) | Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese | |
| NO20022558L (no) | 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor | |
| NO20042861L (no) | N-(3-butyn-1-yl)-N-hydroksyurea | |
| AR040133A1 (es) | Derivados de n-acilamino bencil eter | |
| ATE282615T1 (de) | Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| CA2281918A1 (en) | Oxazolidines as 5-ht2a-antagonists | |
| MY135840A (en) | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | |
| MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
| NO960441L (no) | Benzopyraner og farmasöytiske forbindelser inneholdende dem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |